The 2′,3′-dideoxyriboside of 2,6-diaminopurine and its 2′,3′-didehydro derivative inhibit the deamination of 2′,3′-dideoxyadenosine, an inhibitor of human immunodeficiency virus (HIV) replication
- 1 May 1987
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 145 (1) , 277-283
- https://doi.org/10.1016/0006-291x(87)91317-9
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Human Immunodeficiency VirusScience, 1986
- A Pathogenic Retrovirus (HTLV-III) Linked to AIDSNew England Journal of Medicine, 1984
- Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDSScience, 1984
- Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)Science, 1983
- Inhibitors of adenosine deaminasePharmacology & Therapeutics, 1982
- Synthesis and properties of 2,6-diamino-8,2'-anhydro-8-mercapto-9-.BETA.-D-arabinofuranosylpurine.CHEMICAL & PHARMACEUTICAL BULLETIN, 1981
- Adenosine deaminase from human erythrocytes: Purification and effects of adenosine analogsBiochemical Pharmacology, 1975
- The Role of the 5′-Hydroxyl Group of Adenosine in Determining Substrate Specificity for Adenosine DeaminaseJournal of Medicinal Chemistry, 1967
- Purine Nucleosides. XIV. Unsaturated Furanosyl Adenine Nucleosides Prepared via Base-Catalyzed Elimination Reactions of 2'-Deoxyadenosine Derivatives1Journal of the American Chemical Society, 1966
- Purine Nucleosides. IV. The Synthesis of 6-Halogenated 9-β-D-Ribofuranosylpurines from Inosine and Guanosine1The Journal of Organic Chemistry, 1963